The focus for the HSE and my Department is the full implementation of the CMO’s Report on The Use of Uro-Gynaecological Mesh in Surgical Procedures and ensuring that women who require aftercare following mesh complications receive high quality, multi-disciplinary patient centred care in accordance with the evidence and supported by robust clinical governance mechanisms.
The HSE established a National Vaginal Mesh Implant Oversight Group in 2023 to oversee vaginal mesh implants in our HSE acute hospitals in terms of both primary implant surgery and tertiary complications services.
Listening to the experiences of women affected by mesh remains a key priority for my Department. Work continues to progress with dedicated engagements with Mesh Survivors Ireland and Mesh Ireland and these engagements are central to my Departments review of the work of the HSE’s National Vaginal Mesh Implant Oversight Group.